The treatment also reversed the fragmentation of mitochondria observed in DS and increased the expression of genes of the fission/fusion machinery, namely OPA1 and MFN2 and caused a remodelling of mitochondrial cristae, thus correcting the anomalies observed by electron microscopy in trisomic cells (Izzo et al., 2017b). This evidence concerns the gene MFN2 and Dravet syndrome.